Alkynyl palmitic acid incorporation assay demonstrated that inhibition of AKT and PKC did not alter GLUT1 palmitoylation (Supplementary Fig. 5e), suggesting that GLUT1 palmitoylation is independent of AKT and PKC activation in GBM cells. The gene discussed is SLC2A1; the disease is glioblastoma.